Certolizumab pegol 200 mg sc (with or without MTX) vs placebo (with or without MTX)
Withdrawals due to adverse events · patients with rheumatoid arthritis in adults
Certolizumab pegol 200 mg sc (with or without MTX) leads to higher withdrawals due to adverse events All doses of certolizumab pegol… compared with placebo (with or without MTX) (high certainty).
1 finding from 1 review
- Certolizumab pegol (CDP870) for rheumatoid arthritis in adults 2017 · Cochrane Headline outcomes onlyPeto OR 1.45 [1.09, 1.94]12 studies · 5236 participantsHigh